Publication | Open Access

Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes

Down SyndromeTs65dn ModelPhysiologyNutritional NeuroscienceDegenerative DiseaseDown Syndrome FailsBehavioral Deficits